Morning Market Losers

shares dipped 32.80 percent to $28.93 after the company reported results for the fourth quarter and issued a weak FY16 forecast.

slipped 15.61 percent to $69.89 FBR Capital downgraded World Acceptance from Outperform to Market Perform.

shares dropped 14.15 percent to $2.79 after the company priced an offering of 3,636,364 shares of common stock at $2.75 per share.

shares fell 11.42 percent to $6.98 after the company reported results from LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis.

shares dropped 10.08 percent to $27.48 after the company announced its plans to restructure its LED products unit and also announced a $500 million buyback plan. The company also lowered its revenue outlook for the fourth quarter.

shares declined 3.65 percent to $18.50 after the company priced its 15.935 million share offering by selling shareholders at $18.25 per share.

shares fell 2.77 percent to $25.58. Sabra Health Care REIT priced its 5.9 million share offering at $25.25 per share.